Take a look at some of the biggest movers in the premarket:

Eli Lilly (LLY) – The drug maker's stock fell 3.6% in the premarket after it missed estimates with its quarterly results and cut its full-year forecast. Lilly's performance during the quarter was impacted by lower prices for insulin and falling sales of its Covid-19 treatment.